Oxytocin Buffers Stress Response in Individuals With Impaired Coping Abilities
Oxytocin Buffers Cortisol Responses to Stress in Individuals With Impaired Coping Abilities
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
This study investigated, if people with impaired coping abilities benefit from intranasal oxytocin application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2008
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 8, 2010
CompletedFirst Posted
Study publicly available on registry
February 9, 2010
CompletedFebruary 9, 2010
January 1, 2010
9 months
February 8, 2010
February 8, 2010
Conditions
Outcome Measures
Primary Outcomes (1)
Salivary Cortisol
Study Arms (2)
Oxytocin
EXPERIMENTALIntranasal Oxytocin, 24 IU
Placebo
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- male
You may not qualify if:
- psychological disorders
- drug abuse
- cigarette smoking
- coronary diseases
- nervous system diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 8, 2010
First Posted
February 9, 2010
Study Start
January 1, 2008
Primary Completion
October 1, 2008
Study Completion
October 1, 2008
Last Updated
February 9, 2010
Record last verified: 2010-01